Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia - Authors' reply

Affiliations

¹ Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, Netherlands; Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam, Netherlands.
² Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, Netherlands; Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam, Netherlands. Electronic address: a.j.bredenoord@amsterdamumc.nl.

Comment

Thijs Kuipers et al. Lancet Gastroenterol Hepatol. 2023 Feb.

. 2023 Feb;8(2):114.

doi: 10.1016/S2468-1253(22)00423-X.

¹ Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, Netherlands; Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam, Netherlands.
² Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, Netherlands; Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam, Netherlands. Electronic address: a.j.bredenoord@amsterdamumc.nl.

No abstract available

Conflict of interest statement

We declare no competing interests.

Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia: 5-year follow-up of a randomised controlled trial.
Kuipers T, Ponds FA, Fockens P, Bastiaansen BAJ, Lei A, Oude Nijhuis RAB, Neuhaus H, Beyna T, Kandler J, Frieling T, Chiu PWY, Wu JCY, Wong VWY, Costamagna G, Familiari P, Kahrilas PJ, Pandolfino JE, Smout AJPM, Bredenoord AJ. Kuipers T, et al. Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1103-1111. doi: 10.1016/S2468-1253(22)00300-4. Epub 2022 Oct 4. Lancet Gastroenterol Hepatol. 2022. PMID: 36206786 Clinical Trial.
Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia.
Zhang F, Ge C. Zhang F, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):113-114. doi: 10.1016/S2468-1253(22)00378-8. Lancet Gastroenterol Hepatol. 2023. PMID: 36620982 No abstract available.